- South Korea
- /
- Medical Equipment
- /
- KOSE:A137310
SD Biosensor's (KRX:137310) Strong Earnings Are Of Good Quality
The subdued stock price reaction suggests that SD Biosensor, Inc's (KRX:137310) strong earnings didn't offer any surprises. We think that investors have missed some encouraging factors underlying the profit figures.
How Do Unusual Items Influence Profit?
For anyone who wants to understand SD Biosensor's profit beyond the statutory numbers, it's important to note that during the last twelve months statutory profit was reduced by ₩141b due to unusual items. It's never great to see unusual items costing the company profits, but on the upside, things might improve sooner rather than later. When we analysed the vast majority of listed companies worldwide, we found that significant unusual items are often not repeated. And that's hardly a surprise given these line items are considered unusual. In the twelve months to June 2025, SD Biosensor had a big unusual items expense. All else being equal, this would likely have the effect of making the statutory profit look worse than its underlying earnings power.
That might leave you wondering what analysts are forecasting in terms of future profitability. Luckily, you can click here to see an interactive graph depicting future profitability, based on their estimates.
Our Take On SD Biosensor's Profit Performance
As we discussed above, we think the significant unusual expense will make SD Biosensor's statutory profit lower than it would otherwise have been. Because of this, we think SD Biosensor's underlying earnings potential is as good as, or possibly even better, than the statutory profit makes it seem! And it's also positive that the company showed enough improvement to book a profit this year, after losing money last year. The goal of this article has been to assess how well we can rely on the statutory earnings to reflect the company's potential, but there is plenty more to consider. If you'd like to know more about SD Biosensor as a business, it's important to be aware of any risks it's facing. For example, SD Biosensor has 3 warning signs (and 1 which makes us a bit uncomfortable) we think you should know about.
This note has only looked at a single factor that sheds light on the nature of SD Biosensor's profit. But there is always more to discover if you are capable of focussing your mind on minutiae. Some people consider a high return on equity to be a good sign of a quality business. So you may wish to see this free collection of companies boasting high return on equity, or this list of stocks with high insider ownership.
New: Manage All Your Stock Portfolios in One Place
We've created the ultimate portfolio companion for stock investors, and it's free.
• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
About KOSE:A137310
SD Biosensor
An in-vitro diagnostic company, provides point-of-care diagnostic solutions in South Korea and internationally.
Adequate balance sheet and fair value.
Similar Companies
Market Insights
Community Narratives

